Nu-Med Plus (NUMD) Operating Income Growth (1y) (2013 - 2025)
Nu-Med Plus (NUMD) Operating Income Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 16.18% |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | -116.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.02% |
| Sep 30, 2025 | 42.15% |
| Jun 30, 2025 | 35.04% |
| Mar 31, 2025 | 9.13% |
| Dec 31, 2024 | 83.20% |
| Sep 30, 2024 | -14.99% |
| Jun 30, 2024 | 30.48% |
| Mar 31, 2024 | 23.70% |
| Dec 31, 2023 | -765.44% |
| Sep 30, 2023 | 73.91% |
| Jun 30, 2023 | 60.27% |
| Mar 31, 2023 | 54.79% |
| Dec 31, 2022 | 94.31% |
| Sep 30, 2022 | 50.96% |
| Jun 30, 2022 | 76.96% |
| Mar 31, 2022 | 83.28% |
| Dec 31, 2021 | 77.78% |
| Sep 30, 2021 | 73.68% |
| Jun 30, 2021 | 72.14% |
| Mar 31, 2021 | -132.66% |